IEG Vu is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Marrone faces Nasdaq delisting

The US biopesticide company, Marrone Bio Innovations (MBI - Davis, California), faces delisting from the Nasdaq stock exchange on May 28th unless it receives an extension for submitting financial reports pending a hearing set for June 18th. The company requested a hearing by the Nasdaq listing qualifications panel on May 13th and was granted a 15-day stay of delisting action after failing to submit its financial results for the first quarter of 2015. Marrone has not submitted financial reports since the second quarter of 2014 following an investigation into an $870,000 transaction in the fourth quarter of 2013. It subsequently concluded that reports on the first quarter and first half of 2014 could not be relied upon. A complex examination of sales on a customer-by-customer basis is being carried out and Marrone is unable to say when it will be able to restate its accounts. The listing qualifications panel has the authority to continue the company's listing on the Nasdaq until November 2nd, MBI points out.

Advertisement

Topics

What to read next

Advertisement
UsernamePublicRestriction

Register

AG022421

Ask The Analyst

Please fill in the form below to send over your enquiry or check the Ask The Analyst Page to find out more about the service

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel